...
机译:Aurora激酶抑制剂AMG 900,AZD1152-HQPA和MK-5108对SW-872和93T449人脂肪瘤细胞的临床前评价
Physician Assistant Program College of Health Sciences Midwestern University;
Department of Biomedical Sciences College of Health Sciences Midwestern University;
Department of Biomedical Sciences College of Health Sciences Midwestern University;
Department of Biomedical Sciences College of Health Sciences Midwestern University;
Department of Biomedical Sciences College of Health Sciences Midwestern University;
Department of Microbiology and Immunology Chicago College of Osteopathic Medicine Midwestern University;
Department of Biomedical Sciences College of Health Sciences Midwestern University;
Department of Pharmacology Chicago College of Osteopathic Medicine Midwestern University;
Department of Pharmacology Chicago College of Osteopathic Medicine Midwestern University;
Department of Biomedical Sciences College of Health Sciences Midwestern University;
Department of Biomedical Sciences College of Health Sciences Midwestern University;
Department of Biochemistry Chicago College of Osteopathic Medicine Midwestern University;
Department of Biomedical Sciences College of Health Sciences Midwestern University;
Aurora kinase inhibitors; Liposarcoma; AMG 900; AZD1152-HQPA; MK-5108; SW-872 cell line; 93T449 cell line;
机译:Aurora激酶抑制剂AMG 900,AZD1152-HQPA和MK-5108对SW-872和93T449人脂肪瘤细胞的临床前评价
机译:Aurora激酶抑制剂AMG 900,AZD1152-HQPA和MK-5108对SW-872和93T449人脂肪瘤细胞的临床前评价
机译:对AMG 900的临床前评估,AMG 900是一种新型有效且高度选择性的泛极光激酶抑制剂,在紫杉烷抗性肿瘤细胞系中具有活性。
机译:表皮生长因子受体酪氨酸激酶抑制剂ZD1839(Iressa)通过独立于p53和MMP,uPAR依赖性机制抑制人口腔鳞状细胞癌细胞的增殖和侵袭
机译:磷脂酰肌醇3激酶/蛋白激酶B细胞存活途径抑制剂在胰腺癌治疗中的临床前评价。
机译:Aurora激酶抑制剂AMG900通过破坏有丝分裂进程抑制胶质母细胞瘤细胞增殖
机译:Aurora激酶抑制剂AMG900通过破坏有丝分裂进展来抑制胶质母细胞瘤细胞增殖